GH1 and metabolic syndrome: A recent study demonstrated that hypopituitary patients without GH replacement have more dyslipidemia, but lower homeostasis model assessment (HOMA-IR) and waist/height values, and the occurrence of metabolic syndrome were similar to a control group, paired by age, gender, and Body Mass Index (BMI) [13].